DEGs between TSPAN4 high and low expression groups in PRAD were obtained and further GO/KEGG pathway analysis was applied, which were mainly involved in humoral immune response, protein activation cascade, and receptor ligand activity. The gene discussed is TSPAN4; the disease is prostate adenocarcinoma.